Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Premenopausal Breast Cancer × exemestane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Premenopausal Breast Cancer 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Breast Diseases 1

Interventions

pembrolizumab 1 exemestane 1 Leuprolide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02990845 2023-02-22

PEER

National Taiwan University Hospital

Phase 1/2 Terminated

Premenopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡